Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles: synthesis, antibacterial evaluation and preliminary mechanism of action studies
- 1 April 2019
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 168, 386-404
Abstract
No abstract availableKeywords
Funding Information
- the Australian National Health and Medical Research Council (APP1124032)
- CO-ADD (The Community for Antimicrobial Drug Discovery
This publication has 32 references indexed in Scilit:
- Advances in Development of Antimicrobial Peptidomimetics as Potential DrugsMolecules, 2017
- Emerging trends in antibiotic resistance: Implications for emergency medicineThe American Journal of Emergency Medicine, 2017
- The antibiotic resistance crisis, with a focus on the United StatesThe Journal of Antibiotics, 2017
- Membrane‐Active Small Molecules: Designs Inspired by Antimicrobial PeptidesChemMedChem, 2015
- The global threat of antimicrobial resistance: science for interventionNew Microbes and New Infections, 2015
- Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?Expert Opinion on Drug Discovery, 2015
- Design and synthesis of membrane-targeting antibiotics: from peptides- to aminosugar-based antimicrobial cationic amphiphilesMedChemComm, 2014
- Small Molecular Antibacterial Peptoid Mimics: The Simpler the Better!Journal of Medicinal Chemistry, 2014
- Adaptive Evolution of Escherichia coli to an α-Peptide/β-Peptoid Peptidomimetic Induces Stable ResistancePLOS ONE, 2013
- Clinical relevance of the ESKAPE pathogensExpert Review of Anti-infective Therapy, 2013